Profit or Patient Care? That's the Wrong Question
Margins and patient care do pull against each other. Most boards treat this as an ethics problem they can only worry about. It's really a design problem they can fix.
The tension shows up whenever money logic meets clinical logic: nurses cut to protect margin, volume rewarded over outcomes, a paid procedure chosen over watchful waiting. The comforting line is that "doing good is good for profit." That's only half true, and a board that assumes the two magically align isn't managing the trade-off. It's ducking it.
Treat profit-versus-care as a trade-off to price and watch, not a virtue to claim in the annual report.
Four aims of good care, and a fifth your board should add
Good healthcare is usually summed up in four aims: better patient experience, healthier populations, lower cost per person, and a workforce that isn't burned out. A fifth, fairness of access, was added more recently and matters most of all in India.
Only one of these costs money to chase and saves money to ignore: cost itself. That's the single aim profit pressure squeezes, which points straight to the fix.
It all comes down to how the money flows
This is the idea that turns a moral debate into a business decision. Whether profit and care pull together or apart is set almost entirely by how providers get paid. Pay per service, and more tests and procedures make more money, so profit and care drift apart. Pay per outcome, where you earn by keeping people well and out of hospital, and the two move toward the same goal.
The board's strongest lever isn't a values statement. It's shifting income toward getting paid for outcomes.
In India the tension is sharper, not softer
India sits on the far left of that spectrum. Patients still pay close to half the bill out of pocket, and providers still mostly get paid per service. So the pull toward "do more" rather than "do better" is baked in, showing up as device markups, extra tests, and target-driven care.
Most Indian hospital boards are strong on finance and weak on clinical oversight. For an independent director, the real value isn't another margin review, it's putting patient safety, clinical quality, and fairness of access on the agenda with the same weight as the P&L.
Four boardroom cases
Fortis Healthcare, misalignment
Alleged diversion of funds by controlling promoters pushed one of India's largest chains into crisis, ending in a contested 2018 takeover by IHH. Board lens: a failure of promoter oversight; the mission survived only because outside capital filled the governance hole.
Stent & implant price caps, margin extraction
In 2017 the regulator capped coronary stent prices, then knee implants, after finding very large hospital markups. Board lens: when no one checks the margin taken from patients inside the company, the state steps in and caps it from outside.
Narayana Health, alignment proof
A high-volume, low-cost heart-surgery model with cross-subsidy built in. Standard pathways and scale push cost per patient down while keeping quality and access up. Board lens: proof that lower cost and good care can meet by design, not by sacrifice.
PM-JAY package rates, money flow in action
Ayushman Bharat pays a fixed rate per procedure. Some private hospitals say it's too low and opt out, showing exactly how the payer shapes provider behaviour. Board lens: joining or not is a strategic governance call on reach and fairness, not a billing detail.
Six things a board can actually do
Put a five-aim scorecard in the board pack
Track experience, population health, cost, staff wellbeing, and fairness next to revenue every quarter, with named owners.
Shift income toward paid-for-outcomes
Treat the share of revenue tied to outcomes as a real metric. It's the lever that closes the gap.
Give clinical quality its own board committee
Patient safety deserves the same standing as audit and risk. Don't bury it inside operations.
Stress-test every margin cut
Before approving staffing cuts or volume targets, ask which aims they put at risk, and write down the answer.
Watch promoters and related parties closely
The Fortis lesson: mission risk and governance risk are the same risk. The independent director is the firewall.
Make fairness of access a named goal
Who you don't reach is a governance fact. Measure it and own it, rather than leaving it to CSR reporting.
The board that treats profit-versus-care as a design problem it can fix will out-govern, and over time out-perform, the board still calling it a dilemma it can only describe.